MeSH D009771 - obsessive-compulsive disorder
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001008:Anxiety disorders
D009771:Â
Obsessive-compulsive disorder
D000067836:Hoarding disorder
0 Companies
0 Drugs
Success rate
D000096705:Excoriation disorder
0 Companies
0 Drugs
Success rate
D014256:Trichotillomania
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Citalopram | Celexa |  | 1998-07-17 |  |  |
| Abon Pharmaceuticals | Venlafaxine | Venlafaxine |  | 2025-02-07 |  |  |
| Accord Healthcare | Fluoxetine | Fluoxetine |  | 2020-08-27 |  |  |
| Sertraline | Sertraline |  | 2014-11-07 |  |  | |
| Ajanta Pharma | Clomipramine | Clomipramine |  | 2020-10-02 |  |  |
| Venlafaxine | Venlafaxine |  | 2023-04-12 |  |  | |
| Fluvoxamine | Fluvoxamine |  | 2024-10-17 |  |  | |
| Alembic Pharmaceuticals | Clomipramine | Clomipramine |  | 2021-08-04 |  |  |
| Fluoxetine | Fluoxetine |  | 2009-03-19 |  |  | |
| Venlafaxine | Venlafaxine |  | 2010-12-14 |  |  | |
| Paroxetine | Paroxetine |  | 2025-09-24 |  |  | |
| Alkem Laboratories | Venlafaxine | Venlafaxine |  | 2021-06-10 |  |  |
| Allergan | Fluoxetine | Sarafem |  | 2006-05-19 |  |  |
| Clomipramine | Clomipramine |  | 1996-11-27 |  |  | |
| Fluoxetine | Fluoxetine |  | 2002-01-29 |  |  | |
| Fluvoxamine | Fluvoxamine |  | 2000-12-28 |  |  | |
| Paroxetine | Paroxetine |  | 2017-06-20 |  |  | |
| Almatica Pharma | Citalopram | Citalopram |  | 2022-01-31 |  |  |
| Sertraline | Sertraline |  | 2021-10-04 |  |  | |
| Venlafaxine | Venlafaxine Besylate | 2023-03-27 | 2022-06-29 |  |  | |
| Amneal Pharmaceuticals | Citalopram | Citalopram |  | 2006-11-30 |  |  |
| Clomipramine | Clomipramine |  | 2018-10-31 |  |  | |
| Venlafaxine | Venlafaxine |  | 2010-05-11 |  |  | |
| Anchen Pharmaceuticals | Venlafaxine | Venlafaxine |  | 2012-03-16 |  |  |
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
60%9/15
Phase 2
29%12/42
Phase 3
78%14/18
Approved: 7Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use